Biotherapeutics companies to ‘achieve critical mass’ after merger
HJB and MabSpace merge, combining drug development, commercialization, and GMP manufacturing capabilities, to establish Transcenta.
Archives for January 2, 2019
Novartis makes acquisition to buildout CAR-T capabilities
Novartis will acquire French CDMO, CellforCure, to expand its cell and gene therapy manufacturing network.
Biologics CDMO buys Shire Massachusetts facility
Rentschler Biopharma will buy Shire’s development and manufacturing facility in Milton, Massachusetts, where the latter makes haemophilia A product, Obizur, for commercial production.